Cleared Traditional

K110390 - ETG 255 COMBO STIMUALTOR, TEN 260 STIMUALTOR

K110390 is an FDA 510(k) clearance for ETG 255 COMBO STIMUALTOR, manufactured by Handelshaus Dittman GmbH. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 168-day FDA review.

K110390 · Handelshaus Dittman GmbH · Neurology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
168d
Days
Class 2
Risk

K110390 is an FDA 510(k) clearance for the ETG 255 COMBO STIMUALTOR, TEN 260 STIMUALTOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Handelshaus Dittman GmbH (Shenzhen, CN). The FDA issued a Cleared decision on July 29, 2011 after a review of 168 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K110390

510(k) Number K110390 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 11, 2011
Decision Date July 29, 2011
Days to Decision 168 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d slower than avg
Panel avg: 149d · This submission: 168d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 451
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K110390.
FD TENS 2050 OR SLIDE TENS MODEL FD2050
K111645 · Fuji Dynamics , Ltd. · Nov 2011
QUADRA BLOC TENS PLUS
K102278 · Gradient Technologies, LLC · Oct 2011
KNEEHAB XP
K110350 · Bio-Medical Research, Ltd. · Aug 2011
NEMA-ST, MODEL V1.0.2
K100668 · Nervomatrix, Ltd. · Dec 2010
TENS STIMULATOR, MODELS 2800 AND 3000
K102014 · Koalaty Products, Inc. · Aug 2010
4 CHANNELS MULTIPLE MODEL DIGITAL ELECTRICAL STIMULATOR, MODEL NUVOSTIM IV, WL-2504A
K100399 · Well-Life Healthcare Limited · Jun 2010
K110390 · ETG 255 COMBO STIMUALTOR, TEN 260 STIMUALTOR
Download PDF FDA Summary Handelshaus Dittman G…